Tag Archives: Fluorodeoxyglucose F18/pharmacokinetics

Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)

Arvanitakis Z, Witte RJ, Dickson DW, Tsuboi Y, Uitti RJ, Slowinski J, Hutton ML, Lin SC, Boeve BF, Cheshire WP, Pooley RA, Liss JM, Caviness JN, Strongosky AJ, Wszolek ZK. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord. May 2007;13(4):230-239. Publication Date May 2007 How Analyze was Used…

Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium

Madar I, Ravert HT, Du Y, Hilton J, Volokh L, Dannals RF, Frost JJ, Hare JM. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med. August 2006;47(8):1359-1366. Full Text – Open Access Publication Date August 2006 How Analyze was Used “Image-processing procedures were performed using Analyze…

3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography

Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO. 3′-deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res. July 2003;63(13):3791-3798. Full Text – Open Access Publication Date July 2003 How Analyze was Used…

Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies

Nofzinger EA, Nichols TE, Meltzer CC, Price J, Steppe DA, Miewald JM, Kupfer DJ, Moore RY. Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies. Psychiatry Res. August 1999;91(2):59-78. Publication Date August 1999 How Analyze was Used “The MR data were cropped in preparation for alignment with…